Denis Goldenberg

Denis Goldenberg is a highly accomplished professional with a diverse background in the pharmaceutical and healthcare industries.

Denis Goldenberg attended Millburn High School for his early education and later pursued a Bachelor's degree in Political Science and Business Management from Drew University.

He furthered his education by obtaining an MBA with a focus on Corporate Finance and Pharmaceutical Marketing from Fairleigh Dickinson University-Florham Campus.

Denis Goldenberg currently serves as the Managing Director at Oncolutions, LLC, showcasing his leadership and strategic acumen in the healthcare sector.

Prior to this role, he founded Wings for Wheels and also served as a Mentor at Imerman Angels, highlighting his commitment to philanthropic endeavors.

His extensive professional journey includes significant roles such as VP of Oncology Commercialization at HRA - Healthcare Research & Analytics, Principal at Oncolutions, LLC, and Senior VP of Healthcare Research at Harris Interactive.

Denis Goldenberg has also held senior positions in various renowned organizations, including Senior VP of the Oncology Business Unit at Phoenix Healthcare, US Marketing Lead for deforolimus at Merck, and Director of Oncology Operations at Merck.

His expertise extends to roles such as Director of Marketing for Erbitux (CRC) at ImClone Systems, a subsidiary of Eli Lilly and Company, and Senior Manager of New Products Assessment in Oncology at Pharmacia.

Denis Goldenberg's multidimensional experience in pharmaceutical marketing, oncology operations, and new product assessment reflects his versatile skill set and industry knowledge.

With a strong educational foundation and a proven track record in leadership roles, Denis Goldenberg continues to make valuable contributions to the healthcare and pharmaceutical sectors.